Effects of Total Anthraquinones of Polygonum Cuspidatum on the Levels of Insulin, Leptin and C-Peptide in Serum in Diabete Rat Model

被引:0
作者
Bai, Ming [1 ]
Li, Yan [1 ]
Miao, Mingsan [1 ]
Wang, Ting [1 ]
Xu, Yuyin [1 ]
机构
[1] Henan Univ Tradit Chinese Med, Zhengzhou 450046, Peoples R China
来源
PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON SOCIAL SCIENCE, EDUCATION MANAGEMENT AND SPORTS EDUCATION | 2015年 / 39卷
关键词
Total anthraquinone of Polygonum cuspidatum (TAPC); Diabete model; Streptozotocin; Insulin antibody; Leptin; C-peptide;
D O I
暂无
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
To investigate the effect of total anthraquinone of Polygonum cuspidatum (TAPC) in diabete rats which were established by streptozotocin. Method: The diabete rat model was established by injected with streptozotocin, and then randomized into 5 groups. Which were fed with high dosage TAPC group, medium dosage TAPC group, low dosage TAPC group (400mg.kg(-1), 200mg.kg(-1), 100mg.kg(-1)), metformin group (208 mg.kg(-1)) and model group. Control group was set up with healthy normal rats. All the rats were administrated once a day for 30 days. Blood glucose (BG) in the limosis were measured on the 20, 30 day and then rats were sacrificed. The levels of insulin, insulin antibody, leptin, C-peptide in orbital blood were measured. Results: Diabetic model rats successfully. Compared with model group, The high dosage TAPC group can significantly reduce the level of blood suga on 30 day(P<0.01), Can significantly reduce the level of blood suga on 20 day (P<0.05); The medium dosage TAPC group significantly reduce the level of blood suga on 20, 30 day (P<0.01); The medium and low dosage TAPC group significantly increased the level of insulin (P<0.01); Each dosage TAPC group can significantly reduce the level of C-peptide (P<0.01). Conclusion: TAPC has good hypoglycemic effect on the diabete rats established by injection of streptozotocin
引用
收藏
页码:1270 / 1273
页数:4
相关论文
共 12 条
[1]  
[Anonymous], CHINESE J EXPT TRADI
[2]  
Fan Hui-Ting, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2545
[3]  
[范伟 Fan Wei], 2013, [中国新药杂志, Chinese Journal New Drugs], V22, P2503
[4]  
Huang HL, 2012, J TRADITIONAL CHINES, V25, P100
[5]  
Li Ping, 2011, QILU PHARM AFFAIRS, V30, P232
[6]  
Lin YH, 2010, J ANHUI AGR SCI, V38, P8986
[7]  
[苗明三 Miao Mingsan], 2011, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V28, P896
[8]  
Miao MS, 2014, MECHATRONICS MECH EN, V664, P397
[9]  
Miao MS, 2014, APPL MECH, V664, P388, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.664.388
[10]  
Qin Y., 2012, CONTINUING MED ED, V26, P46